Targeting syndecan-1: new opportunities in cancer therapy.

Zecheng Yang, Shuaitong Chen, Haoqiang Ying, Wantong Yao

American journal of physiology. Cell physiology 2022 Jul 01

filter terms:

Syndecan-1 (SDC1, CD138) is one of the heparan sulfate proteoglycans and is essential for maintaining normal cell morphology, interacting with the extracellular and intracellular protein repertoire, as well as mediating signaling transduction upon environmental stimuli. The critical role of SDC1 in promoting tumorigenesis and metastasis has been increasingly recognized in various cancer types, implying a promising potential of utilizing SDC1 as a novel target for cancer therapy. This review summarizes the current knowledge on SDC1 structure and functions, including its role in tumor biology. We also discuss the highlights and limitations of current SDC1-targeted therapies as well as the obstacles in developing new therapeutic methods, offering our perspective on the future directions to target SDC1 for cancer treatment.

Citation

Zecheng Yang, Shuaitong Chen, Haoqiang Ying, Wantong Yao. Targeting syndecan-1: new opportunities in cancer therapy. American journal of physiology. Cell physiology. 2022 Jul 01;323(1):C29-C45